ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 25, 2026
ProtoKinetix Market Cap
ProtoKinetix has a market cap or net worth of $82.33 thousand as of September 25, 2026. Its market cap has decreased by -96.53% in one year.
Market Cap
82.33K
Enterprise Value
81.21K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 82.33K, an increase of 36.36%. That is a compound annual growth rate of 1.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 82.33K | -96.62% |
| Dec 31, 2025 | 2.43M | -34.52% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CNBX Pharmaceuticals | 160.58K |
| Affymax | 148.98K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| GB Sciences | 105.88K |
| Innovation Pharmaceuticals | 105.75K |
| Sigyn Therapeutics | 88.50K |
| Itoco | 85.64K |